COVID-19 RESPONSE

The REDS-IV-P program launches RESPONSE – REDS Epidemiology, Surveillance and Preparedness of the Novel SARS-CoV-2 Epidemic – a project co-sponsored by NIAID and NHLBI. This project intends to answer key questions about theoretical blood safety concerns, seroincidence in blood donors, and to further our understanding of the SARS-CoV-2 pathogenesis through infected donor and patient follow-up studies. Additional … Read more

COVID-19 RESPONSE

The REDS-IV-P program launches RESPONSE – REDS Epidemiology, Surveillance and Preparedness of the Novel SARS-CoV-2 Epidemic – a project co-sponsored by NIAID and NHLBI. This project intends to answer key questions about theoretical blood safety concerns, seroincidence in blood donors, and to further our understanding of the SARS-CoV-2 pathogenesis through infected donor and patient follow-up studies. Additional … Read more

Hemostasis Clinical Trial Outcomes Working Group

REGISTER TODAY9/23/19 – 9/24/19Natcher Conference CenterBuilding 45 Bethesda MD, 20894 Hemostasis Clinical Trial Outcomes Working Group The development and execution of clinical trials that evaluate hemostatic products are impeded by the lack of commonly accepted outcomes by the necessary funding and regulatory agencies. The establishment of clinically relevant outcomes that are widely accepted for patients … Read more

REDS-IV-P Fall Domestic Steering Committee Meeting

We are pleased to announce the dates for the Fall in-person REDS-IV-P Domestic and Brazil Steering Committee Meetings. September 26-27, 2019 This two-day meeting will take place at Westat’s Rockville campus at 1600 Research Blvd, Rockville, MD, 20850 Online attendee information to be posted closer to the date.

NHLBI awards REDS-IV-P

NHLBI awards REDS-IV-P, a 7yr multicenter program in the US & Brazil that seeks to improve the safety & effectiveness of transfusion therapies w/ attention to not only adults but also neonates & children. Learn about the different phases of REDS and its contributions here.